  See all
 |
Articles: Chemotherapy/Oncology |
Prior Articles
Evaluation of in vivo antineoplastic effects of rapamycin in patients with chemotherapy-refractory AML
European Journal of Internal Medicine, 11/06/09
From somatostatin to octreotide LAR: evolution of a somatostatin analogue
Current Medical Research and Opinion, 11/05/09 Critical appraisal of temozolomide formulations in the treatment of primary brain tumors: patient considerations
Cancer Management and Research, 11/05/09
Free full text
MDR1 polymorphism role in patients treated with cetuximab and irinotecan in irinotecan refractory colorectal cancer
Medical Oncology, 11/04/09 Current status of maintenance therapy for advanced ovarian cancer
International Journal of Women's Health, 11/03/09
Free full text
Antivascular agents for non-small-cell lung cancer: current status and future directions
Expert Opinion on Investigational Drugs, 11/03/09 The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer
Expert Opinion on Investigational Drugs, 11/03/09 Activity of ketoconazole after taxane-based chemotherapy in castration-resistant prostate cancer
BJU International, 11/02/09 Identification of Compounds Selectively Killing Multidrug-Resistant Cancer Cells
Cancer Research, 11/02/09
Exclusive Author Commentary Clinical compliance with an oral uracil/tegafur (UFT) plus leucovorin (LV) regimen as adjuvant chemotherapy in Japanese colorectal cancer patients
International Journal of Clinical Oncology, 11/02/09 Anti-Malignancy Agent/Anti-VEGF Humanized Monoclonal Antibody, Avastin: Application for Approval of Additional Indication of Breast Cancer
Chugai Pharmaceutical Co., 11/02/09
Free full text
Lapatinib in metastatic breast cancer
Women's Health, 10/30/09 Chemotherapy for lung cancer: the state of the art in 2009
Expert Review of Anticancer Therapy, 10/30/09 Relationships between FSH, inhibin B, anti-Mullerian hormone and testosterone during long-term treatment with the GnRH-agonist Histrelin in patients with prostate cancer
European Journal of Endocrinology, 10/30/09 Clinical outcome of patients with non-small cell lung cancer receiving front-line chemotherapy according to EGFR and K-RAS mutation status
Lung Cancer, 10/30/09 Expression of ERCC1 and class IIIbeta tubulin for predicting effect of carboplatin/paclitaxel in patients with advanced inoperable non-small cell lung cancer
Pathology International, 10/30/09 Susceptibility to urinary bladder cancer: relevance of rs9642880[T], GSTM1 0/0 and occupational exposure
Pharmacogenetics and genomics, 10/30/09 Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
Trends in Pharmacological Sciences, 10/29/09 The role of surveillance in the treatment of patients with muscle-invasive bladder cancer after chemotherapy
BJU International, 10/29/09 A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer
Cancer Chemotherapy and Pharmacology, 10/29/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|
